Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CVN424 is a selective and novel GPR6 Inverse agonist effective in models of Parkinson Disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 97.00 | |
5 mg | In stock | $ 255.00 | |
10 mg | In stock | $ 396.00 | |
25 mg | In stock | $ 663.00 | |
50 mg | In stock | $ 945.00 | |
100 mg | In stock | $ 1,280.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 266.00 |
Description | CVN424 is a selective and novel GPR6 Inverse agonist effective in models of Parkinson Disease. |
In vivo | CVN424 is brain-penetrant and shows dose-dependent receptor occupancy that attained brain 50% of receptor occupancy at plasma concentrations of 6.0 and 7.4 ng/ml in mice and rats, respectively[1]. |
Molecular Weight | 473.52 |
Formula | C24H29F2N5O3 |
CAS No. | 2254706-21-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60mg/mL (126.71 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CVN424 2254706-21-1 Endocrinology/Hormones GPCR/G Protein GPR penetrant GPR6 inhibit orally brain Inhibitor CVN 424 Parkinson disease CVN-424 inhibitor